Request More Information

Simoa® Advantage Plus Assays


Introducing Simoa® Advantage PLUS, the latest advancement for Quanterix RUO assay kits. Simoa® Advantage PLUS assays were carefully designed to improve longitudinal data precision and better support for large-scale research studies. Developed by integrating invaluable customer insights and cutting-edge technology, Simoa® Advantage PLUS assay technology brings new lot-to-lot consistency and sustainability to previous chemistry innovations as a testament to an unwavering dedication to delivering the gold standard in industry-leading ultra-sensitive assays. 


From discovery to diagnostics, our Simoa® Advantage PLUS assays can fuel your research through the ability to identify and examine critical biomarkers less invasively, more efficiently, and with higher accuracy when compared to other analog methods.  

Jump to form

Scientist with Simoa HD-X

Powering the Driving Force in Biomarker Research

With the introduction of Simoa® Advantage PLUS, Quanterix sets a new benchmark for RUO assay kits. Emphasizing lot-to-lot consistency, increased lot sizes, and sustainability, we showcase our unwavering dedication to ensuring industry-leading assay performance and stability. 

Complete the form for more info and to download our one-page information sheet.

Enhanced Lot-to-Lot Consistency: Improved protocols and manufacturing methods ensure consistent results and optimize lot-to-lot consistency.  

Increased Lot Sizes: New manufacturing efficiencies enable production of larger lot sizes. 

Efficient Storage & Shipping: Reagent improvements and innovative packaging consolidate components into a single box, making storage at 2-8°C efficient and negating the need for freezer space and dry ice during shipping. 


Benefits of Simoa® Advantage PLUS

Enhanced Data Precision: Capture and discriminate subtle differences in samples across lots, facilitating more accurate long-term analysis and conclusions. 

Support for Large-Scale Research Studies: Larger lots sizes, enhanced lot-to-lot reliability, and extended shelf-life ensures large-scale and longitudinal research studies are supported with unparalleled consistency. 

Single-Lot Sourcing: Extended shelf-life allows large studies that prefer single-lot sourcing to purchase one bulk order with confidence. 

Reduced Carbon Footprint: Streamlined packaging and efficient storage and shipping contribute to environmental sustainability by decreasing overall energy consumption and associated emissions. 

Unparalleled Sensitivity: The robustness of assay parameters remains paramount, ensuring that the sensitivity levels you have come to trust remains undiminished. 


Key Biomarkers Immediately Available 

  • NfL 
  • IFN-a MS 
  • sTREM2 
  • IL-17A 
  • pTau-181

Simoa® Advantage PLUS combines the power of Quanterix’s instrument technology and Simoa® ultra-sensitive digital immunoassays to elevate the precision, consistency, efficiency, and sustainability of your biomarker research. Don't miss the opportunity to revolutionize your data collection and analysis with this cutting-edge solution. 


Complete the form to download our one-pager and request more information from your sales rep about Advantage Plus.

Where Precision Meets Innovation

Simoa Accelerator Lab

Simoa® Advantage PLUS

Developed by integrating invaluable customer insights and cutting-edge advancements, Advantage PLUS stands as a testament to Quanterix’s unwavering dedication to delivering the gold standard in industry-leading ultra-sensitive assays.

Simoa Assays

HD-X™ Automated Immunoassay Analyzer

Unleash the potential of groundbreaking discoveries in neurology, oncology, infectious diseases, and more with Simoa® bead technology with our flagship HD-X automated immunoassay analyzer, offering ultrasensitive multiplex biomarker detection.

Simoa Homebrew Assay

Simoa® Assay Kits

Ready-to-use Simoa® kits contain all the reagents necessary to run your assay on the HD-1, HD-X , SR-X or SP-X platforms. Our broad portfolio of available kits spans multiple therapeutic areas including cardiology, infectious disease, inflammation, neurology, and oncology.